CHILDREN'S HEALTHCARE OF ATLANTA

Nivolumab and brentuximab vedotin were tested in a large Hodgkin lymphoma trial, including pediatric patients, showing potential for earlier access to checkpoint inhibitors. The study, led by Dr. Kara Kelly and Dr. Sharon Castellino, aims to reduce radiation therapy in advanced-stage patients, with significant implications for reducing late effects in children and adolescents.

After frequent bruises led to a leukemia diagnosis for Ally, her family faced a challenging treatment journey. Precision medicine revealed Ally and her father share Lynch syndrome, increasing cancer risk. Now cancer-free, Ally uses her experience to raise awareness and funds for childhood cancer.